2003
DOI: 10.1016/s0278-5846(02)00340-8
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
28
2
3

Year Published

2004
2004
2016
2016

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(36 citation statements)
references
References 38 publications
3
28
2
3
Order By: Relevance
“…The resulting increase in oxidative activity provokes an increase in circulating levels of SOD as a protective response, as has been described in patients with TD [11]. Preliminary data supports the use of antioxidants in reversing and/or treating TD [25,26,44], which has raised hopes that these agents may be useful in protecting against the later development of TD in patients who need to receive neuroleptics, viz. the treatment of schizophrenia.…”
Section: Discussionmentioning
confidence: 59%
“…The resulting increase in oxidative activity provokes an increase in circulating levels of SOD as a protective response, as has been described in patients with TD [11]. Preliminary data supports the use of antioxidants in reversing and/or treating TD [25,26,44], which has raised hopes that these agents may be useful in protecting against the later development of TD in patients who need to receive neuroleptics, viz. the treatment of schizophrenia.…”
Section: Discussionmentioning
confidence: 59%
“…Chronic reserpine treatment also significantly decreased reduced glutathione, an endogenous antioxidant and cellular antioxidant enzymes superoxide dismutase and catalase levels, further supporting the involvement of free radical toxicity in reserpine-induced orofacial dyskinesia. Other investigators have also demonstrated that reserpine-induced oral dyskinesia is closely associated with the oxidative stress process (Calvente et al, 2002;Abilio et al, 2003;Burger et al, 2003). Sussman et al (1997) reported that it is possible that reserpine-induced orofacial dyskinesia may be initiated by altered striatal dopaminergic function, but the persistent neuropathological changes involve GABAergic efferent to striatal dopamine.…”
Section: Discussionmentioning
confidence: 99%
“…Conversely, the protocol used here (repeated treatment with a low dose) reduced tyrosine hydroxylase staining in the substantia nigra and striatum, and part of the alterations induced by the treatment were not recovered after 30 days of treatment withdrawal [8]. Second, it has been shown that reserpine treatment increases brain oxidative stress and this alteration is accompanied by behavioral deficits [10,22,23]. In addition, in a previous study [9] the repeated treatment with a low dose of reserpine induced an increase in striatal level of lipid peroxidation, which occurred concomitantly to the motor impairment.…”
Section: Discussionmentioning
confidence: 82%
“…blockage of the vesicular transport of monoamines), there is clear evidence that reserpine also causes an increase in cellular oxidative stress, possibly potentiated by the rise in the levels of dopamine in the cytoplasm, which undergoes oxidative metabolism [10]. In this respect, the central nervous system is quite vulnerable to reactive oxygen species (ROS), which play a very important function in the pathogenesis of neurodegenerative disorders, including PD [11].…”
Section: Introductionmentioning
confidence: 99%